Albert H. Kim, MD, PhD - Publications

Affiliations: 
Washington University School of Medicine, St. Louis, MO, United States 
Area:
Cancer biology, Neurobiology

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mahlokozera T, Patel B, Chen H, Desouza P, Qu X, Mao DD, Hafez D, Yang W, Taiwo R, Paturu M, Salehi A, Gujar AD, Dunn GP, Mosammaparast N, Petti AA, ... ... Kim AH, et al. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. Nature Communications. 12: 6321. PMID 34732716 DOI: 10.1038/s41467-021-26653-6  0.717
2019 Mahlokozera T, Paturu M, Hafez D, Mao D, Kim AH. The TRIM26-SOX2 Ubiquitin Signaling Axis Regulates the Maintenance and Tumorigenicity of Glioblastoma Stem-like Cells Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_215  0.385
2019 Paturu M, Salehi A, Caine M, Mahlokozera T, Yano H, Leuthardt E, Klein R, Schmidt R, Kim A. EXTH-35. LASER INTERSTITIAL THERMAL THERAPY INCREASES BLOOD-BRAIN BARRIER AND BLOOD-TUMOR BARRIER PERMEABILITY IN A MOUSE MODEL OF GLIOBLASTOMA Neuro-Oncology. 21: vi89-vi89. DOI: 10.1093/Neuonc/Noz175.367  0.308
2019 Tran D, Campian J, Shimony J, Kim A, Ansstas G, Leuthardt E. SCIDOT-43. FINAL DATA ANALYSIS OF A PILOT STUDY TESTING THE EFFICACY OF USING LASER INTERSTITIAL THERMAL THERAPY (LITT) TO INDUCE TEMPORARY DISRUPTION OF THE PERITUMORAL BLOOD BRAIN BARRIER (BBB) TO IMPROVE EFFECTIVENESS OF BBB-IMPERMEANT CHEMOTHERAPY IN RECURRENT GLIOBLASTOMA Neuro-Oncology. 21: vi280-vi281. DOI: 10.1093/Neuonc/Noz175.1179  0.301
2019 Campian J, Ghiaseddin A, Rahman M, Huang J, Ansstas G, Kim A, Leuthardt E, Tran D. ATIM-45. LONG TERM FOLLOW-UP OF A PHASE I/II STUDY TESTING THE TOXICITIES AND EFFICACY OF PEMBROLIZUMAB IN COMBINATION WITH MRI-GUIDED LASER INTERSTITIAL THERMAL THERAPY (LITT) IN RECURRENT MALIGNANT GLIOMAS Neuro-Oncology. 21: vi11-vi11. DOI: 10.1093/Neuonc/Noz175.043  0.328
2018 Taiwo R, Mahlokozera T, Kim AH. Erratum to stem nourished by branches: glioblastomas co-opt classic neurotrophic factor signaling to maintain stem-like cell pool. Stem Cell Investigation. 5: 48. PMID 30701183 DOI: 10.21037/Sci.2018.11.06  0.3
2018 Pan Y, Zhu Y, Yang W, Tycksen E, Liu S, Palucki J, Zhu L, Sasaki Y, Sharma MK, Kim AH, Zhang B, Yano H. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity. The Journal of Biological Chemistry. PMID 29891550 DOI: 10.1074/Jbc.Ra117.001211  0.34
2018 Gujar AD, Mao DD, Finlay JB, Kim AH. Establishing Primary Human Glioblastoma Adherent Cultures from Operative Specimens. Methods in Molecular Biology (Clifton, N.J.). 1741: 53-62. PMID 29392689 DOI: 10.1007/978-1-4939-7659-1_3  0.716
2018 Huang J, Campian JL, Gujar AD, Tsien C, Ansstas G, Tran DD, DeWees TA, Lockhart AC, Kim AH. Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma. Journal of Neuro-Oncology. PMID 29374809 DOI: 10.1007/S11060-018-2775-Y  0.711
2018 Mahlokozera T, Taiwo R, Mao D, Salehi A, Gujar A, Kim A. STEM-07. NON-CANONICAL REGULATION OF SOX2 BY THE TRIM26 E3 UBIQUITIN LIGASE IN GLIOBLASTOMA STEM-LIKE CELLS Neuro-Oncology. 20: vi245-vi245. DOI: 10.1093/Neuonc/Noy148.1014  0.716
2017 Wu M, Guan J, Li C, Gunter S, Nusrat L, Ng S, Dhand K, Morshead C, Kim A, Das S. Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma. Oncotarget. 8: 82217-82230. PMID 29137258 DOI: 10.18632/Oncotarget.19283  0.354
2017 Slat EA, Sponagel J, Marpegan L, Simon T, Kfoury N, Kim A, Binz A, Herzog ED, Rubin JB. Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma. Journal of Biological Rhythms. 32: 121-129. PMID 28470120 DOI: 10.1177/0748730417696788  0.322
2017 Huang J, Campian J, Gujar A, Tsien C, Ansstas G, Tran D, Dewees T, Kim A, Lockhart AC. Actr-21. Updated Results Of A Phase I Dose-Escalation, Dose-Expansion Study Of Disulfiram And Adjuvant Temozolomide For Newly Diagnosed Glioblastoma Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.016  0.703
2016 Gujar AD, Le S, Mao DD, Dadey DY, Turski A, Sasaki Y, Aum D, Luo J, Dahiya S, Yuan L, Rich KM, Milbrandt J, Hallahan DE, Yano H, Tran DD, ... Kim AH, et al. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27930300 DOI: 10.1073/Pnas.1610921114  0.733
2016 Pan Y, Daito T, Sasaki Y, Chung YH, Xing X, Pondugula S, Swamidass SJ, Wang T, Kim AH, Yano H. Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity. Scientific Reports. 6: 31022. PMID 27516062 DOI: 10.1038/Srep31022  0.329
2016 Gujar AD, Yano H, Kim AH. The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma. Molecular & Cellular Oncology. 3: e1075644. PMID 27314081 DOI: 10.1080/23723556.2015.1075644  0.742
2016 Huang J, Campian JL, Gujar AD, Tran DD, Lockhart AC, DeWees TA, Tsien CI, Kim AH. A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. Journal of Neuro-Oncology. PMID 26966095 DOI: 10.1007/S11060-016-2104-2  0.715
2016 Kang SK, Murphy RK, Hwang SW, Lee SM, Harburg DV, Krueger NA, Shin J, Gamble P, Cheng H, Yu S, Liu Z, McCall JG, Stephen M, Ying H, Kim J, ... ... Kim AH, et al. Bioresorbable silicon electronic sensors for the brain. Nature. PMID 26779949 DOI: 10.1038/Nature16492  0.697
2016 Gujar A, Turski A, Le S, Mao D, Dadey D, Aum D, Luo J, Hallahan D, Tran D, Yano H, Kim A. CSIG-20. IDENTIFICATION OF A NAMPT-E2F2-ID1 SIGNALING AXIS IN GLIOBLASTOMA Neuro-Oncology. 18: vi45-vi45. DOI: 10.1093/Neuonc/Now212.181  0.706
2015 Sengupta R, Barone A, Marasa J, Taylor S, Jackson E, Warrington NM, Rao S, Kim AH, Leonard JR, Piwnica-Worms D, Rubin JB. Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions. Oncotarget. 6: 18282-92. PMID 26286961 DOI: 10.18632/Oncotarget.4957  0.304
2015 Mao DD, Gujar AD, Mahlokozera T, Chen I, Pan Y, Luo J, Brost T, Thompson EA, Turski A, Leuthardt EC, Dunn GP, Chicoine MR, Rich KM, Dowling JL, Zipfel GJ, ... ... Kim AH, et al. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells. Cell Reports. 11: 1809-21. PMID 26074073 DOI: 10.1016/J.Celrep.2015.05.027  0.751
2015 Gujar A, Mahlokozera T, Mao D, Pan Y, Yano H, Kim A. STEM-11MECHANISMS OF CDC20-ANAPHASE-PROMOTING COMPLEX ACTION IN HUMAN GLIOBLASTOMA STEM-LIKE CELLS Neuro-Oncology. 17: v210.3-v210. DOI: 10.1093/Neuonc/Nov234.11  0.744
2015 Huang J, Campian J, Gujar A, Tran D, Lockhart AC, DeWees T, Tsien C, Kim A. ATNT-11A PHASE I PHARMACODYNAMIC STUDY OF DISULFIRAM AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA AFTER RADIATION THERAPY AND CONCURRENT TEMOZOLOMIDE Neuro-Oncology. 17: v12.3-v12. DOI: 10.1093/Neuonc/Nov205.11  0.72
2014 Aum DJ, Kim DH, Beaumont TL, Leuthardt EC, Dunn GP, Kim AH. Molecular and cellular heterogeneity: the hallmark of glioblastoma. Neurosurgical Focus. 37: E11. PMID 25434380 DOI: 10.3171/2014.9.Focus14521  0.308
2014 Brooks MD, Jackson E, Warrington NM, Luo J, Forys JT, Taylor S, Mao DD, Leonard JR, Kim AH, Piwnica-Worms D, Mitra RD, Rubin JB. PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells. Plos One. 9: e107397. PMID 25203500 DOI: 10.1371/Journal.Pone.0107397  0.334
2013 Puram SV, Kim AH, Park HY, Anckar J, Bonni A. The ubiquitin receptor S5a/Rpn10 links centrosomal proteasomes with dendrite development in the mammalian brain. Cell Reports. 4: 19-30. PMID 23831032 DOI: 10.1016/J.Celrep.2013.06.006  0.735
2011 Puram SV, Riccio A, Koirala S, Ikeuchi Y, Kim AH, Corfas G, Bonni A. A TRPC5-regulated calcium signaling pathway controls dendrite patterning in the mammalian brain. Genes & Development. 25: 2659-73. PMID 22135323 DOI: 10.1101/Gad.174060.111  0.775
2011 Puram SV, Kim AH, Ikeuchi Y, Wilson-Grady JT, Merdes A, Gygi SP, Bonni A. A CaMKIIβ signaling pathway at the centrosome regulates dendrite patterning in the brain. Nature Neuroscience. 14: 973-83. PMID 21725312 DOI: 10.1038/Nn.2857  0.781
2010 Puram SV, Kim AH, Bonni A. An old dog learns new tricks: a novel function for Cdc20-APC in dendrite morphogenesis in neurons. Cell Cycle (Georgetown, Tex.). 9: 482-5. PMID 20195072 DOI: 10.4161/Cc.9.3.10558  0.736
2010 Yang Y, Kim AH, Bonni A. The dynamic ubiquitin ligase duo: Cdh1-APC and Cdc20-APC regulate neuronal morphogenesis and connectivity. Current Opinion in Neurobiology. 20: 92-9. PMID 20060286 DOI: 10.1016/J.Conb.2009.12.004  0.673
2009 Yang Y, Kim AH, Yamada T, Wu B, Bilimoria PM, Ikeuchi Y, de la Iglesia N, Shen J, Bonni A. A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation. Science (New York, N.Y.). 326: 575-8. PMID 19900895 DOI: 10.1126/Science.1177087  0.772
2009 Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nature Medicine. 15: 331-7. PMID 19198615 DOI: 10.1038/Nm.1912  0.518
2009 Kim AH, Puram SV, Bilimoria PM, Ikeuchi Y, Keough S, Wong M, Rowitch D, Bonni A. A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell. 136: 322-36. PMID 19167333 DOI: 10.1016/J.Cell.2008.11.050  0.764
2008 Kim AH, Bonni A. Cdk1-FOXO1: a mitotic signal takes center stage in post-mitotic neurons. Cell Cycle (Georgetown, Tex.). 7: 3819-22. PMID 19124971 DOI: 10.4161/Cc.7.24.7215  0.647
2007 Kim AH, Bonni A. Thinking within the D box: initial identification of Cdh1-APC substrates in the nervous system. Molecular and Cellular Neurosciences. 34: 281-7. PMID 17223572 DOI: 10.1016/J.Mcn.2006.11.019  0.627
2003 Kim AH, Sasaki T, Chao MV. JNK-interacting protein 1 promotes Akt1 activation. The Journal of Biological Chemistry. 278: 29830-6. PMID 12783873 DOI: 10.1074/Jbc.M305349200  0.536
2002 Kim AH, Yano H, Cho H, Meyer D, Monks B, Margolis B, Birnbaum MJ, Chao MV. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron. 35: 697-709. PMID 12194869 DOI: 10.1016/S0896-6273(02)00821-8  0.549
2002 Lee FS, Rajagopal R, Kim AH, Chang PC, Chao MV. Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. The Journal of Biological Chemistry. 277: 9096-102. PMID 11784714 DOI: 10.1074/Jbc.M107421200  0.639
2001 Lee FS, Kim AH, Khursigara G, Chao MV. The uniqueness of being a neurotrophin receptor. Current Opinion in Neurobiology. 11: 281-6. PMID 11399425 DOI: 10.1016/S0959-4388(00)00209-9  0.751
2001 Kim AH, Khursigara G, Sun X, Franke TF, Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Molecular and Cellular Biology. 21: 893-901. PMID 11154276 DOI: 10.1128/Mcb.21.3.893-901.2001  0.761
1999 Kong H, Kim AH, Orlinick JR, Chao MV. A comparison of the cytoplasmic domains of the Fas receptor and the p75 neurotrophin receptor. Cell Death and Differentiation. 6: 1133-42. PMID 10578183 DOI: 10.1038/Sj.Cdd.4400587  0.482
1999 Kerchner GA, Kim AH, Choi DW. Glutamate-Mediated Excitotoxicity Handbook of Experimental Pharmacology. 141: 443-469. DOI: 10.1007/978-3-662-08022-1_14  0.316
Show low-probability matches.